/sent on behalf of

Dr. Ben Albensi

DEMENTIA JOURNAL CLUB

Wednesday, April 28th, 2021

12:00 PM (noon)

Zoom link

https://us02web.zoom.us/j/83383153871?pwd=YVVxUXdHWmljUlV0elJSSEFITStPQT09

Meeting ID: 833 8315 3871

Passcode: 744024

Dr. R. Scott Turner, M.D., Ph.D.

Vice Chair for Clinical Research

Professor, Department of Neurology

Director, Memory Disorders Program - Georgetown University

Dr. Turner's research is focused on developing new treatments and biomarkers for neurodegenerative diseases of aging, particularly Mild Cognitive Impairment and dementia due to Alzheimer's disease. Dr. Turner is on the steering committees of the Alzheimer's Disease Cooperative Study (ADCS) and the Alzheimer's Therapeutic Research Institute (ATRI), and is a site PI for the NIH-funded Alzheimer's Clinical Trials Consortium (ACTC) and Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD). He is PI or Site PI on numerous multi-center, randomized, placebo-controlled clinical trials, including Resveratrol for Alzheimer's disease and Nilotinib for Alzheimer's disease.

All are welcome to attend!

For more information contact Dr. Ben Albensi, balbensi@sbrc.ca mailto:balbensi@sbrc.ca

******************************************

http://www.manitobaneuroscience.ca/

https://www.facebook.com/manitobaneuroscience/?fref=ts https://www.instagram.com/manitobaneuroscience/ https://twitter.com/manitobaneuro